Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

The test substance was tested for its mutagenic potential in vitro based on the ability to induce point mutations in selected loci of several bacterial strains in a reverse mutation assay according to OECD Guideline 471 under GLP conditions. Based on the results of this study, the test substance is not mutagenic in the reverse mutation assay in the absence and the presence of metabolic activation.

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Mar - Apr 2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
21 Jul 1997
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
(from the competent authority) Landesamt für Umwelt Rheinland-Pfalz
Type of assay:
bacterial reverse mutation assay
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Batch No.of test material: 170492F01
- Expiration date of the Batch: 22 Jun 2019
- Purity: 100.0 area-% (HPLC fingerprint)
- Content:
21.4 g/100 g Test item
23.5 g/100 g (NH4)2C4H4O6
30 g/100 g Tartrate
6.7 g/100 g Ammonium
9.1 g/100 g Antimony
53.5 g/100 g Water
- Physical state, appearance: liquid, colorless to yellowish, clear

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
- Stability under test conditions: The stability of the test substance (aqueous solution) throughout the study period was guaranteed as indicated by the sponsor, therefore the stability of the test substance in the vehicle water was expected.

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test substance was weighed and topped up with the chosen vehicle to achieve the required concentration of the stock solution. The test substance was dissolved in water (= ultrapure water). To achieve a clear solution of the test substance in the vehicle, the test substance preparation was shaken thoroughly. The further concentrations were diluted from the stock solution according to the planned doses. All test substance formulations were prepared immediately before administration.

FORM AS APPLIED IN THE TEST (if different from that of starting material): aqueous solution
Target gene:
his, trp
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
phenobarbital and ß-naphthoflavone induced rat liver S9
Test concentrations with justification for top dose:
0; 100; 500; 1000; 2750; 5500 and 11000 µg/plate (Experiment 1 and Experiment 2, respectively)
In agreement with the recommendations of current guidelines 5 mg/plate or 5 µL/plate were generally selected as maximum test dose at least in the 1st Experiment. However, this maximum dose was tested even in the case of relatively insoluble test compounds to detect possible mutagenic impurities. Furthermore, doses > 5 mg/plate or > 5 µL/plate might also be tested in repeat experiments for further clarification / substantiation.
In this study, due to the purity of the test substance 11.0 mg/plate was used as top dose in all experiments.
Vehicle / solvent:
- Vehicle used: water
- Justification for choice of vehicle: Due to the good solubility of the test substance in water, water was used as vehicle.
Untreated negative controls:
yes
Remarks:
sterility control
Negative solvent / vehicle controls:
yes
Remarks:
vehicle control
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
other: 2-aminoanthracene (with S9 mix; 2.5 µg/plate dissolved in DMSO for TA 1535, TA 100, TA 1537 & TA 98; 60 µg/plate dissolved in DMSO for E.coli WP2 uvrA)
Remarks:
further positive control substances: N-methyl-N'-nitro-N-nitrosoguanidine (without S9 mix; 5 µg/plate dissolved in DMSO for TA 1535 & TA 100), 4-nitro-o-phenylenediamine (without S9 mix; 10 µg/plate dissolved in DMSO for TA 98)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 20 min (PIT)
- Exposure duration: 48 - 72 h (SPT & PIT)

DETERMINATION OF CYTOTOXICITY
- Method: decrease in the number of revertants (factor ≤ 0.6), clearing or diminution of the background lawn (= reduced his- or trp- background growth)
Evaluation criteria:
Mutagenicity:
Individual plate counts, the mean number of revertant colonies per plate and the standard deviations were given for all dose groups as well as for the positive and negative (vehicle) controls in all experiments. In general, six doses of the test substance were tested with a maximum of 5 mg/plate, and triplicate plating was used for all test groups at least in the 1st Experiment. Dose selection and evaluation as well as the number of plates used in repeat studies or further experiments were based on the findings in the 1st Experiment.

Toxicity:
Toxicity detected by a
- decrease in the number of revertants (factor ≤ 0.6)
- clearing or diminution of the background lawn (= reduced his- or trp- background growth)
was recorded for all test groups both with and without S9 mix in all experiments and indicated in the tables. Single values with a factor ≤ 0.6 were not detected as toxicity in low dose groups.

Solubility:
If precipitation of the test material was observed, it would be recorded and indicated in the tables. As long as precipitation did not interfere with the colony scoring, 5 mg/plate was generally selected and analyzed (in cases of nontoxic compounds) as the maximum dose at least in the 1st Experiment even in the case of relatively insoluble test compounds to detect possible mutagenic impurities. Furthermore, doses > 5 mg/plate might also be tested in repeat experiments for further clarification / substantiation.
Statistics:
Acceptance criteria:
Generally, the experiment was considered valid if the following criteria were met
- The number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain.
- The sterility controls revealed no indication of bacterial contamination.
- The positive control substances both with and without S9 mix induced a distinct increase in the number of revertant colonies compatible with the range of the historical positive control data or above.
- Fresh bacterial culture containing approximately 10^9 cells per mL were used.

Assessment criteria:
The test substance was considered positive in this assay if the following criteria were met
- A dose-related and reproducible increase in the number of revertant colonies, i.e. at least doubling (bacteria strains with high spontaneous mutation rate, like TA 98, TA 100 and E.coli WP2 uvrA) or tripling (bacteria strains with low spontaneous mutation rate, like TA 1535 and TA 1537) of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.
A test substance was generally considered non-mutagenic in this test if
- The number of revertants for all tester strains were within the range of the historical negative control data under all experimental conditions in at least two experiments carried out independently of each other.
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
SPT with S9 mix from 5500 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
PIT without S9 from 5500 µg/plate & with S9 from 11000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
SPT with S9 & PIT without S9 from 11000 µg/plate, respectively
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No test substance precipitation was found with and without S9 mix.

HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: see tables in any other information on results
- Negative (solvent/vehicle) historical control data: see tables in any other information on results

ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: A weak bacteriotoxic effect (slight decrease in the number of his+ revertants) was observed in the standard plate test and in the preincubation assay depending on the strain and test conditions from about 5500 µg/plate onward.

DISCUSSION
According to the results of the present study, the test substance did not lead to a relevant increase in the number of revertant colonies without S9 mix or after adding a metabolizing system in two experiments carried out independently of each other (standard plate test and preincubation assay).
Besides, the results of the negative as well as the positive controls performed in parallel corroborated the validity of this study, since the values fulfilled the acceptance criteria.
In this study with and without S9 mix, the number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain.
In addition, the positive control substances with and without S9 mix induced a significant increase in the number of revertant colonies compatible with the range of the historical positive control data.

Table 1: Decreased revertant numbers were observed at following concentrations [µg/plate]

Experiment

S9

TA 1535

TA 100

TA 1537

TA 98

E.coli

1st – SPT

Without

-

-

-

-

-

With

5500 – 11000

-

-

11000

-

2nd – PIT

Without

-

-

5500 – 11000

11000

-

With

-

-

11000

-

-

Table 2: Standard plate test without metabolic activation

Strain

Test group

Dose [µg/plate]

Mean revertants per plate

Standard deviation

Factor

Individual revertant colony counts

TA 1535

Water

Test item

 

 

 

 

 

MNNG

-

100

500

1000

2750

5500

11000

5.0

8.0

8.7

9.0

9.3

9.7

7.3

9.7

5933.3

2.6

2.9

2.0

5.0

5.5

2.1

4.6

365.5

-

1.1

1.1

1.2

1.2

0.9

1.2

741.7

7, 6, 11

12, 7, 7

9, 11, 7

10, 14, 4

7, 16, 6

9, 5, 8

7, 7, 15

6024, 6245, 5531

TA 100

Water

Test item

 

 

 

 

 

MNNG

-

100

500

1000

2750

5500

11000

5.0

118.0

126.3

141.7

127.0

143.0

125.7

115.7

4294.0

27.5

4.2

28.0

5.6

12.3

10.0

11.8

133.0

-

1.1

1.2

1.1

1.2

1.1

1.0

36.4

119, 145, 90

125, 131, 123

148, 111, 166

128, 121, 132

148, 152, 129

122, 118, 137

122, 102, 123

4160, 4296, 4426

TA 1537

Water

Test item

 

 

 

 

 

AAC

-

100

500

1000

2750

5500

11000

100

9.0

7.3

7.3

9.7

4.7

6.3

6.3

849.0

1.0

2.5

2.1

1.5

2.1

1.2

1.5

136.0

-

0.8

0.8

1.1

0.5

0.7

0.7

94.3

9, 10, 8

5, 10, 7

5, 9, 8

8, 11, 10

4, 3, 7

7, 7, 5

6, 5, 8

692, 925, 930

TA 98

Water

Test item

 

 

 

 

 

NOPD

-

100

500

1000

2750

5500

11000

10

20.3

20.7

14.3

19.0

24.0

21.7

13.7

1132.0

2.1

8.3

2.5

4.6

3.0

8.1

3.2

77.1

-

1.0

0.7

0.9

1.2

1.1

0.7

55.7

22, 18, 21

14, 30, 18

12, 14, 17

15, 24, 18

21, 24, 27

16, 31, 18

16, 10, 15

1192, 1159, 1045

E.coli

Water

Test item

 

 

 

 

 

4-NQO

-

100

500

1000

2750

5500

11000

5

33.0

31.7

28.3

26.0

28.3

21.7

30.3

766.3

7.2

5.8

6.1

3.6

3.5

2.5

7.0

18.2

-

1.0

0.9

0.8

0.9

0.7

0.9

23.2

35, 39, 25

35, 35, 25

35, 27, 23

30, 23, 25

28, 25, 32

24, 22, 19

31, 37, 23

763, 786, 750

Table 3: Standard plate test with metabolic activation

Strain

Test group

Dose [µg/plate]

Mean revertants per plate

Standard deviation

Factor

Individual revertant colony counts

TA 1535

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

13.7

10.3

11.0

8.7

11.0

7.7

6.7

210.7

1.5

2.5

1.0

1.5

1.0

1.5

3.1

5.7

-

0.8

0.8

0.6

0.8

0.6

0.5

15.4

15, 14, 12

13, 8, 10

12, 10, 11

9, 10, 7

10, 12, 11

9, 8, 6

10, 6, 4

206, 217, 209

TA 100

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

127.0

114.3

129.0

111.3

114.3

115.3

117.0

1565.0

5.3

16.1

15.1

5.1

12.5

8.3

17.4

117.3

-

0.9

1.0

0.9

0.9

0.9

0.9

12.3

129, 131, 121

121, 96, 126

143, 131, 113

110, 117, 107

123, 100, 120

122, 106, 118

129, 97, 125

1691, 1545, 1459

TA 1537

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

7.3

6.7

8.3

8.0

8.3

9.7

8.3

90.0

3.1

2.9

2.1

1.0

4.2

1.2

2.5

8.0

-

0.9

1.1

1.1

1.1

1.3

1.1

12.3

4, 10, 8

5, 10, 5

6, 10, 9

7, 8, 9

13, 5, 7

11, 9, 9

6, 11, 8

90, 98, 82

TA 98

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

30.7

29.7

26.3

27.3

28.3

22.0

18.0

1033.0

6.1

7.6

6.8

11.6

1.5

2.6

7.5

91.7

-

1.0

0.9

0.9

0.9

0.7

0.6

33.7

32, 36, 24

28, 38, 23

21, 34, 24

38, 29, 15

30, 28, 27

21, 20, 25

10, 19, 25

1102, 1068, 929

E.coli

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

60

24.0

28.3

27.0

27.0

30.0

30.0

26.7

92.7

1.7

4.0

1.0

5.3

1.0

5.6

4.0

1.5

-

1.2

1.1

1.1

1.3

1.3

1.1

3.9

25, 22, 25

32, 24, 29

26, 28, 27

25, 23, 33

31, 29, 30

35, 24, 31

29, 29, 22

93, 94, 91

Table 4: Preincubation test without metabolic activation

Strain

Test group

Dose [µg/plate]

Mean revertants per plate

Standard deviation

Factor

Individual revertant colony counts

TA 1535

Water

Test item

 

 

 

 

 

MNNG

-

100

500

1000

2750

5500

11000

5.0

9.7

8.3

7.0

8.7

12.0

8.0

8.0

2417.3

4.5

2.5

2.0

3.1

3.6

2.6

1.7

309.5

-

0.9

0.7

0.9

1.2

0.8

0.8

250.1

5, 10, 14

11, 6, 8

5, 7, 9

8, 6, 12

11, 16, 9

7, 6, 11

10, 7, 7

2493, 2077, 2682

TA 100

Water

Test item

 

 

 

 

 

MNNG

-

100

500

1000

2750

5500

11000

5.0

109.3

102.0

112.7

104.3

102.3

102.0

116.3

3483.3

10.2

15.7

4.7

11.2

14.2

16.8

7.8

252.7

-

0.9

1.0

1.0

0.9

0.9

1.1

31.9

105, 102, 121

109, 113, 84

111, 109, 118

114, 92, 107

115, 87, 105

83, 115, 108

110, 125, 114

3772, 3376, 3302

TA 1537

Water

Test item

 

 

 

 

 

AAC

-

100

500

1000

2750

5500

11000

100

9.0

5.3

8.3

11.7

10.0

5.3

5.3

807.7

2.0

2.1

2.5

2.5

3.6

4.0

0.6

123.6

-

0.6

0.9

1.3

1.1

0.6

0.6

89.7

7, 9, 11

3, 7, 6

11, 6, 8

9, 14, 12

7, 14, 9

10, 3, 3

6, 5, 5

950, 727, 746

TA 98

Water

Test item

 

 

 

 

 

NOPD

-

100

500

1000

2750

5500

11000

10

21.3

18.3

19.3

16.7

19.0

17.7

12.7

1234.0

6.5

5.0

6.4

4.6

1.7

7.2

3.1

113.2

-

0.9

0.9

0.8

0.9

0.8

0.6

57.8

21, 15, 28

13, 19, 23

23, 23, 12

14, 22, 14

18, 21, 18

26, 14, 13

12, 16, 10

1287, 1311, 1104

E.coli

Water

Test item

 

 

 

 

 

4-NQO

-

100

500

1000

2750

5500

11000

5

30.0

35.3

32.7

27.3

24.7

25.7

26.3

526.3

7.0

3.2

5.8

4.6

5.0

1.5

2.3

73.0

-

1.2

1.1

0.9

0.8

0.9

0.9

17.5

30, 23, 37

39, 33, 34

26, 36, 36

22, 30, 30

24, 20, 30

27, 24, 26

25, 29, 25

569, 568, 442

Table 5: Preincubation test with metabolic activation

Strain

Test group

Dose [µg/plate]

Mean revertants per plate

Standard deviation

Factor

Individual revertant colony counts

TA 1535

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

7.0

10.0

5.7

9.7

6.7

8.0

6.7

206.0

2.0

4.0

1.5

2.3

2.1

1.0

2.5

17.8

-

1.4

0.8

1.4

1.0

1.1

1.0

29.4

5, 7, 9

6, 14, 10

7, 4, 6

11, 11, 7

5, 9, 6

9, 7, 8

9, 7, 4

200, 192, 226

TA 100

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

111.3

118.0

103.0

104.3

126.3

123.0

109.3

2141.0

6.1

18.0

12.5

20.5

11.5

15.5

5.5

37.2

-

1.1

0.9

0.9

1.1

1.1

1.0

19.2

110, 118, 106

123, 133, 98

115, 90, 104

92, 93, 128

133, 113, 133

124, 138, 107

104, 115, 109

2170, 2099, 2154

TA 1537

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

9.0

9.0

9.7

7.0

11.3

7.3

5.7

127.3

3.5

3.6

0.6

3.5

0.6

5.0

1.5

14.2

-

1.0

1.1

0.8

1.3

0.8

0.6

14.1

13, 7, 7

8, 13, 6

9, 10, 10

9, 3, 9

11, 11, 12

2, 8, 12

6, 7, 4

111, 137, 134

TA 98

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

2.5

24.7

27.0

23.7

21.7

20.3

22.0

19.0

1494.3

2.5

4.4

5.9

7.5

3.1

9.2

1.7

318.9

-

1.1

1.0

0.9

0.8

0.9

0.8

60.6

27, 22, 25

32, 25, 24

28, 26, 17

22, 14, 29

23, 21, 17

12, 30, 24

18, 18, 21

1234, 1399, 1850

E.coli

Water

Test item

 

 

 

 

 

2-AA

-

100

500

1000

2750

5500

11000

60

30.3

30.7

29.0

23.0

28.7

30.0

23.0

127.3

7.1

1.5

6.6

6.2

4.0

3.0

4.6

16.1

-

1.0

1.0

0.8

0.9

1.0

0.8

4.2

29, 24, 38

29, 31, 32

28, 36, 23

16, 28, 25

33, 28, 25

33, 27, 30

28, 22, 19

134, 139, 109

Table 6: Historical negative control data

Strain

S9 Mix

Vehicle

No. of Plates

No. of Values

Min

Max

Mean

SD

TA 1535

Without

With

(All)

(All)

414

414

152

152

7

6

16

18

10

10

2.0

2.0

TA 100

Without

With

(All)

(All)

426

417

152

153

71

70

132

147

100

107

11.4

13.7

TA 1537

Without

With

(All)

(All)

411

411

152

152

5

5

13

16

8

9

1.7

2.1

TA 98

Without

With

(All)

(All)

420

413

152

152

14

12

34

38

21

28

3.3

4.5

E.coli

Without

With

(All)

(All)

396

399

152

152

15

17

34

36

24

25

3.9

4.4

Table 7: Historical positive control data

Strain

S9 Mix

Positive Control

No. of Plates

No. of Values

Min

Max

Mean

SD

TA 1535

Without

With

MNNG

2-AA

312

312

110

110

1541

105

6171

520

3967

197

1253.9

56.3

TA 100

Without

With

MNNG

2-AA

315

309

110

111

1126

272

5557

3021

3298

1748

1109.6

587.2

TA 1537

Without

With

AAC

2-AA

309

312

110

110

253

50

2190

399

1044

141

404.3

50.3

TA 98

Without

With

NOPD

2-AA

309

315

110

110

324

493

1746

3096

863

1524

206.8

529.1

E.coli

Without

With

4-NQO

2-AA

306

306

110

110

164

61

1721

537

860

133

431.9

61.8

Conclusions:
Under the experimental conditions chosen here, it is concluded that the test substance is not a mutagenic test substance in the bacterial reverse mutation test in the absence and the presence of metabolic activation.
Executive summary:

The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay.

Strains: TA 1535, TA 100, TA 1537, TA 98 and E.coli WP2 uvrA

Dose Range: 100 µg - 11000 µg/plate (SPT), 100 µg - 11000 µg/plate (PIT)

Test Conditions: Standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats).

Solubility: No precipitation of the test substance was found with and without S9 mix.

Toxicity: A weak bacteriotoxic effect was occasionally observed depending on the strain and test conditions from about 5500 µg/plate onward.

Mutagenicity: A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system.

Under the experimental conditions of this study, the test substance is not mutagenic in the Salmonella typhimurium / Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Genetic toxicity in vitro

Ames

The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay.

Strains: TA 1535, TA 100, TA 1537, TA 98 and E.coli WP2 uvrA

Dose Range: 100 µg - 11000 µg/plate (SPT), 100 µg - 11000 µg/plate (PIT)

Test Conditions: Standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats).

Solubility: No precipitation of the test substance was found with and without S9 mix.

Toxicity: A weak bacteriotoxic effect was occasionally observed depending on the strain and test conditions from about 5500 µg/plate onward.

Mutagenicity: A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system.

Under the experimental conditions of this study, the test substance is not mutagenic in the Salmonella typhimurium / Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.

Justification for classification or non-classification

Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008

The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. No indication of genotoxicity was observed in the Ames test (OECD 471, GLP). As a result, the substance is not considered to be classified for mutagenicity under Regulation (EC) No. 1272/2008, as amended for the tenth time in Regulation (EC) No. 2017/776.